Xiaolan Lu
Impact in
-
- Hepatocellular Carcinoma Treatment and Prognosis
-
- SARS-CoV-2 and COVID-19 Research
- SARS-CoV-2 detection and testing
- COVID-19 Clinical Research Studies
Papers in
- Epidemiology 10
- Liver Disease Diagnosis and Treatment 8
- Hepatitis B Virus Studies 2
-
- SARS-CoV-2 and COVID-19 Research 3
- COVID-19 Clinical Research Studies 3
- SARS-CoV-2 detection and testing 2
- Co-authors
- Qin Du (7 shared papers)Xiaolan Guo (6 shared papers)Qiang Wang (6 shared papers)Guoyuan Zhang (4 shared papers)Bin Guo (1 shared paper)Bing Zhang (1 shared paper)Qiang Ma (1 shared paper)Fang Li (1 shared paper)
- Journals
- Scientific Reports (4 papers)World Journal of Gastroenterology (2 papers)Cellular and Molecular Biology (1 paper)Frontiers in Pharmacology (1 paper)Journal of Clinical Microbiology (1 paper)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Xiaolan Lu
32 papers receiving 478 citations
Peers
Comparison fields: 5 of 78
- Hepatology 42
- Infectious Diseases 88
- Pathology and Forensic Medicine 67
- Cancer Research 54
- Epidemiology 93
Countries citing papers authored by Xiaolan Lu
This map shows the geographic impact of Xiaolan Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaolan Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaolan Lu more than expected).
Fields of papers citing papers by Xiaolan Lu
This network shows the impact of papers produced by Xiaolan Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaolan Lu. The network helps show where Xiaolan Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaolan Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 91 | |
| 2 | 2004 | 56 | |
| 3 | 2019 | 54 | |
| 4 | 2019 | 31 | |
| 5 | 2016 | 31 | |
| 6 | 2016 | 26 | |
| 7 | 2017 | 22 | |
| 8 | 2019 | 19 | |
| 9 | 2023 | 19 | |
| 10 | 2015 | 18 | |
| 11 | 2019 | 18 | |
| 12 | 2019 | 17 | |
| 13 | 2020 | 16 | |
| 14 | 2013 | 9 | |
| 15 | 2018 | 7 | |
| 16 | 2003 | 7 | |
| 17 | 2008 | 6 | |
| 18 | 2016 | 5 | |
| 19 | 2023 | 4 | |
| 20 | 2015 | 4 |
About Xiaolan Lu
Xiaolan Lu is a scholar working on Epidemiology, Infectious Diseases, Molecular Biology, Pathology and Forensic Medicine and Surgery, having authored 33 papers that have together received 489 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (8 papers), SARS-CoV-2 and COVID-19 Research (3 papers), COVID-19 Clinical Research Studies (3 papers), Hepatitis B Virus Studies (2 papers), Inflammatory mediators and NSAID effects (2 papers), Cell death mechanisms and regulation (2 papers), Peroxisome Proliferator-Activated Receptors (2 papers) and SARS-CoV-2 detection and testing (2 papers). The work is most often cited by research in Hepatology (42 citations), Infectious Diseases (88 citations), Pathology and Forensic Medicine (67 citations), Cancer Research (54 citations) and Epidemiology (93 citations). Xiaolan Lu has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Qin Du, Xiaolan Guo, Qiang Wang, Guoyuan Zhang, Bin Guo, Bing Zhang, Qiang Ma, Fang Li, Zhiming Tang and Dongsheng Wang. Their work appears in journals such as Scientific Reports, World Journal of Gastroenterology, Cellular and Molecular Biology, Frontiers in Pharmacology and Journal of Clinical Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.